Fingerprint
Dive into the research topics of 'Ofatumumab versus Teriflunomide in Multiple Sclerosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ofatumumab versus Teriflunomide in Multiple Sclerosis
Stephen L. Hauser, ASCLEPIOS I and ASCLEPIOS II Trial Groups, Andrejs Millers (Member of the Working Group), Guntis Karelis (Member of the Working Group)
Research output: Contribution to journal › Article › peer-review
389
Citations
(Scopus)